Research ArticleOriginal Article
Open Access

Follicular aspiration versus coasting for ovarian hyper-stimulation syndrome prevention

Nayla J. Bushaqer, Nawal M. Dayoub, Khalsa K. AlHattali, Hisham A. Ayyoub, Samaher S. AlFaraj and Samar N. Hassan
Saudi Medical Journal March 2018, 39 (3) 290-295; DOI: https://doi.org/10.15537/smj.2018.3.22331

References

  1. ↵
    1. Habek D,
    2. Bauman R,
    3. Kralj LR,
    4. Hafner T,
    5. Turudic T,
    6. Vujisic S
    (2016) Acute abdomen in the 17th week of twin pregnancy due to ovarian torsion–a late complication of IVF. Geburtshilfe Frauenheilkd 76:1345–1349.
    OpenUrl
  2. ↵
    1. Piróg MM,
    2. Jach R,
    3. Undas A
    (2016) Thromboprophylaxis in women undergoing gynecological surgery or assisted reproductive techniques: new advances and challenges. Ginekol Pol 87:773–779.
    OpenUrl
  3. ↵
    1. Corbett S,
    2. Shmorgun D,
    3. Claman P,
    4. Cheung A,
    5. Sierra S,
    6. Carranza-Mamane B,
    7. et al.
    (2014) The prevention of ovarian hyperstimulation syndrome. J Obstet Gynaecol Can 36:1024–1033.
    OpenUrl
  4. ↵
    1. El Tokhy O,
    2. Kopeika J,
    3. El-Toukhy T
    (2016) An update on the prevention of ovarian hyperstimulation syndrome. Womens Health (Lond) 12:496–503.
    OpenUrl
  5. ↵
    1. Nastri CO,
    2. Teixeira DM,
    3. Moroni RM,
    4. Leitão VM,
    5. Martins WP
    (2015) Ovarian hyperstimulation syndrome: pathophysiology, staging, prediction and prevention. Ultrasound Obstet Gynecol 45:377–393.
    OpenUrl
  6. ↵
    1. Smith V,
    2. Osianlis T,
    3. Vollenhoven B
    (2015) Prevention of ovarian hyperstimulation syndrome: a review. Obstet Gynecol Int 2015:514159.
    OpenUrl
  7. ↵
    1. Chen CD,
    2. Chen SU,
    3. Yang YS
    (2012) Prevention and management of ovarian hyperstimulation syndrome. Best Pract Res Clin Obstet Gynaecol 26:817–827.
    OpenUrlPubMed
  8. ↵
    1. Orvieto R
    (2013) Ovarian hyperstimulation syndrome-an optimal solution for an unresolved enigma. J Ovarian Res 6:77.
    OpenUrl
  9. ↵
    1. Gonen Y,
    2. Powell WA,
    3. Casper RF
    (1991) Effect of follicular aspiration on hormonal parameters in patients undergoing ovarian stimulation. Hum Reprod 6:356–358.
    OpenUrlCrossRefPubMed
  10. ↵
    1. Egbase PE,
    2. Sharhan MA,
    3. Grudzinskas JG
    (1999) Early unilateral follicular aspiration compared with coasting for the prevention of severe ovarian hyperstimulation syndrome: a prospective randomized study. Hum Reprod 14:1421–1425.
    OpenUrlCrossRefPubMedWeb of Science
  11. ↵
    1. Egbase PE,
    2. Makhseed M,
    3. Al Sharhan M,
    4. Grudzinskas JG
    (1997) Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotrophin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study. Hum Reprod 12:2603–2606.
    OpenUrlCrossRefPubMedWeb of Science
  12. ↵
    1. Chahvar ST,
    2. Zosmer A,
    3. Caragia A,
    4. Balestrini S,
    5. Sabatini L,
    6. Tranquilli AL,
    7. et al.
    (2014) Coasting, embryo development and outcomes of blastocyst transfer: a case–control study. Reprod Biomed Online 29:231–238.
    OpenUrl
  13. ↵
    1. Fiedler K,
    2. Ezcurra D
    (2012) Predicting and preventing ovarian hyperstimulation syndrome (OHSS): the need for individualized not standardized treatment. Reprod Biol Endocrinol 10:32.
    OpenUrlCrossRefPubMed
  14. ↵
    1. Mourad S,
    2. Brown J,
    3. Farquhar C
    (2017) Interventions for the prevention of OHSS in ART cycles: an overview of Cochrane reviews. Cochrane Database Syst Rev 1:CD012103.
    OpenUrlPubMed
  15. ↵
    1. Pfeifer S,
    2. Butts S,
    3. Dumesic D,
    4. Fossum G,
    5. Gracia C,
    6. La Barbera A,
    7. et al.
    (2016) Prevention and treatment of moderate and severe ovarian hyperstimulation syndrome: a guideline. Fertility and sterility 106:1634–1647.
    OpenUrlPubMed
  16. ↵
    1. Humaidan P,
    2. Nelson SM,
    3. Devroey P,
    4. Coddington CC,
    5. Schwartz LB,
    6. Gordon K,
    7. et al.
    (2016) Ovarian hyperstimulation syndrome: review and new classification criteria for reporting in clinical trials. Hum Reprod 31:1997–2004.
    OpenUrlCrossRefPubMed
  17. ↵
    1. Tomaževič T,
    2. Meden-Vrtovec H
    (1996) Early timed follicular aspiration prevents severe ovarian hyperstimulation syndrome. J Assist Reprod Genet 13:282–286.
    OpenUrlCrossRefPubMedWeb of Science
  18. ↵
    1. Vrtovec HM,
    2. Tomazevic T
    (1995) Preventing severe ovarian hyperstimulation syndrome in an in vitro fertilization/embryo transfer program. Use of follicular aspiration after human chorionic gonadotropin administration. J Reprod Med 40:37–40.
    OpenUrlPubMedWeb of Science
  19. ↵
    1. Amit A,
    2. Yaron Y,
    3. Yovel I,
    4. Peyser MR,
    5. David MP,
    6. Botchan A,
    7. et al.
    (1993) Endocrinology: repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders. Human Reproduction 8:1184–1186.
    OpenUrlCrossRefPubMedWeb of Science
  20. ↵
    1. Oyawoye OA,
    2. Chander B,
    3. Hunter J,
    4. Gadir AA
    (2005) Prevention of ovarian hyperstimulation syndrome by early aspiration of small follicles in hyper-responsive patients with polycystic ovaries during assisted reproductive treatment cycles. MedGenMed 7:60.
    OpenUrlPubMed
  21. ↵
    1. Duvan ZC,
    2. Kalem MN,
    3. Onaran Y,
    4. Keskin EA,
    5. Ayrım A,
    6. Pekel A,
    7. et al.
    (2017) The effect of coasting on intracytoplasmic sperm injection outcome in antagonist and agonist cycle. Int J Fertil Steril 11:1.
    OpenUrl
  22. ↵
    1. Leitao VM,
    2. Moroni RM,
    3. Seko LM,
    4. Nastri CO,
    5. Martins WP
    (2014) Cabergoline for the prevention of ovarian hyperstimulation syndrome: systematic review and meta-analysis of randomized controlled trials. Fertil Steril 101:664–675.
    OpenUrlCrossRefPubMed
  23. ↵
    1. D'Angelo A,
    2. Brown J,
    3. Amso NN
    (2011) Coasting (withholding gonadotrophins) for preventing ovarian hyperstimulation syndrome. Cochrane Database Syst Rev, 6.
  24. ↵
    1. Boothroyd C,
    2. Karia S,
    3. Andreadis N,
    4. Rombauts L,
    5. Johnson N,
    6. Chapman M
    (2015) Consensus statement on prevention and detection of ovarian hyperstimulation syndrome. Aust N Z J Obstet Gynaecol 55:523–534.
    OpenUrl
  25. ↵
    1. Moon HS,
    2. Joo BS,
    3. Moon SE,
    4. Lee SK,
    5. Kim KS,
    6. Koo JS
    (2008) Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Fertil Steril 90:2172–2178.
    OpenUrlCrossRefPubMed
  26. ↵
    1. Yumuşak ÖH,
    2. Kahyaoğlu S,
    3. Erdinç AS,
    4. Yılmaz S,
    5. Üstün YE,
    6. Yılmaz N
    (2014) Does the serum E2 level change following coasting treatment strategy to prevent ovarian hyperstimulation syndrome impact cycle outcomes during controlled ovarian hyperstimulation and in vitro fertilization procedure? Turk J Obstet Gynecol 11:159.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section